Antiproliferative responses of two human colon cancer cell lines to vitamin D3 are differentially modified by 9-cis-retinoic acid

Cancer Research

Volumn 56, Issue 3, 1996, Pages 623-632

  Kane, Katherine F ^a   Langman, Michael J S ^a   Williams, Graham R ^a,b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CALCIFEDIOL; CALCITRIOL; CALCITRIOL RECEPTOR; MESSENGER RNA; OXYGENASE; RETINOIC ACID RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SPECIFICITY; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CACO-2 CELLS; CALCITRIOL; CELL DIVISION; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HT29 CELLS; HUMANS; KINETICS; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; STEROID HYDROXYLASES; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 0030020067     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Bikle, D. D. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr Rev., 13: 765-782, 1992
2. 3 on primary cultures of human prostatic cells. Cancer Res , 54: 805-810, 1994.
3. Mathiasen, I. S., Colston, K. W., and Binderup, L EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J. Steroid Biochem. Mol Biol., 46: 365-371, 1993
4. 3 co-operate in vitro to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes Leukemia (Baltimore), 8: 806-815, 1994.
5. Owen, T. A , Aronow, M. S., Barone, L. M., Bettencourt, B , Stein, G S., and Lian, J. B Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency on basal levels of gene expression, duration of exposure and bone matrix competency in normal rat osteoblast cultures. Endocrinology, 128: 1496-1504, 1991.
6. Garland, C., Shekelle, R. B., Barrett-Connor, E., Crique, R. B., Rossof, A. H., and Paul, O. Dietary vitamin D and calcium and risk if colorectal cancer: a 19-year prospective study in men. Lancet, 1: 307-309, 1985
7. Garland, C F , Comstock, G. W., Garland, F. C., Felsing, K., Shaw, E. K., and Gorham, E D Serum 25-hydroxyvitamin D and colon cancer eight year prospective study. Lancet. 2: 1176-1178, 1989.
8. 3. Carcinogenesis (Lond.), 9: 187-190, 1988.
9. Sitrin, M. D , Halline, A. G., Abrahams, C., and Brasitus, T. A. Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res., 51: 5608-5613, 1991.
10. 3 in chemically induced rat colon carcinogenesis. Carcinogenesis (Lond.), 13. 2293-2298, 1992
11. Beaty, M. M , Lee, E. Y., and Glauert, H. P. Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets. J. Nutr., 123: 144-152, 1993.
12. 3. Cancer Res , 47: 21-25, 1987.
13. 3 receptor and induction of differentiation by the hormone J. Steroid Biochem., 29: 265-270, 1988.
14. Guiliano, A. R., Franceschi, R. T., and Wood, R J. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch. Biochem. Biophys., 285: 261-269, 1991.
15. Zhao, X., and Feldman, D. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology, 132: 1808-1814, 1993.
16. 3 on proliferation and differentiation of Caco-2 cells Endocrinology, 134: 1710-1717, 1994.
17. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res., 53: 3712-3718, 1993.
18. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol , 42. 1569-1575, 1991.
19. Binderup, L., and Bramm, E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo Biochem. Pharmacol., 37: 889-895, 1991.
20. 3. J Bone Miner. Res., 6: 1021-1027, 1991.
21. Evans, R M. The steroid and thyroid hormone receptor superfamily. Science (Washington DC). 240: 889-895, 1988.
22. 3 signaling. Nature (Lond.), 355: 446-449, 1992.
23. Yu, V. C , Delsert, C , Andersen, B., Holloway, J. M., Devary, O V., Naar, A. M., Kim, S. Y., Boutin, J-M., Glass, C. K., and Rosenfeld, M. G. RXR-β: a coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell, 67: 1251-1266, 1991.
24. Cheskis, B , and Freedman, L P. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers Mol Cell. Biol., 14: 3329-3338, 1994
25. Williams, G. R Solving the specificity puzzle. Nature (Lond.), 370: 330-331, 1994.
26. 3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell. Biol., 15: 1154-1161, 1995.
27. Thomas, M. G., Tebbutt, S., and Williamson, R. C. N. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut, 33. 1660-1663, 1992.
28. Berger, U., Wilson, P., McClelland, R. A., Colston, K., Haussler, M. R., Pike, J. W., and Coombes, R. C. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J. Clin. Endocrinol & Metab., 67: 607-613, 1988.
29. 3 receptors in human colorectal adenocarcinoma and normal mucosa Cancer Res., 51. 1227-1233, 1991.
30. 3 and retinoid X receptor expression in human colorectal neoplasms Gut, 36: 255-258, 1995.
31. Kane, K F , Michell, N P , Langman, M. J. S., and Williams, G R. Functional vitamin D receptors are present in human colorectal neoplasms. Gastroenterology, 108. A487, 1995.
32. 3 to calcitroic acid. Biochem. J., 262: 178-180, 1989.
33. Rubin, M., Fenig, E , Rosenauer, A., Menendez-Botet, C., Achkar, C , Bentel, J. M., Yahalom, J., Mendelson, J , and Miller, W. H. 9-cis-Retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein Cancer Res., 54: 6549-6556, 1994.
34. Philips, R. W., Kikendall, J. W., Luk, G. D., Willis, S. M , Murphy, J. R , Maydonovitch, C., Bowen, P. E , Stacewicz-Sapuntzakis, M., and Wong, R. K H. β-Carotene inhibits rectal mucosal ornithine decarboxylase activity in colon cancer patients. Cancer Res., 53: 3723-3725, 1993
35. Stopera, S. A., and Bird, R. P. Effects of all-trans-retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci, differential expression of c-myc and c-fos mRNA and protein. Int J. Cancer. 53: 798-804, 1993.
36. Samuels, H. H., and Tsai, J. S. Thyroid hormone action: demonstration of similar receptors in isolated nuclei of rat liver and cultured GH4 cells. J. Clin. Invest., 53: 656-659, 1974.
37. Chomczynski, P., and Sacchi, N Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction. Anal Biochem., 162: 156-159, 1987.
38. Ausubel, F M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Current Protocols in Molecular Biology. New York: Greene Publishing, 1992.
39. Baker, A. R., McDonnell, D. P., Hughes, M , Crisp, T M., Mangelsdan, D. J., Hausslev, M. R., Pike, J. W., Shine, J., and O'Malley, B. W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad Sci. USA, 85: 3294-3298, 1988.
40. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A., and Evans, R. M Nuclear receptor that identifies a novel retinoic acid response pathway. Nature (Lond.) 345. 224-229, 1990.
41. Mangelsdorf, D. J., Borgmeyer, U., Heyman, R. A , Zhou, J. Y , Ong, E S., Oro, A E., Kakizuka, A., and Evans, R. M. Characterization of three RXR genes that mediate the action of 9-cis-retinoic acid. Genes & Dev , 6: 329-344, 1992.
42. 3 24-hydroxlase cDNA. Proc. Natl. Acad. Sci. USA. 90: 4543-4547, 1993.
43. 3. J. Biol. Chem., 259. 1167-1169, 1984.
44. 3. J. Mol. Endocrinol , 7: 185-195, 1991.
45. Carlberg, C., Bendik, I., Wyss, A , Meier, E., Sturzenbecker, L. J., Grippo, J. F., and Hunziker, W. Two nuclear signalling pathways for vitamin D. Nature (Lond.), 361. 657-660, 1993.
46. Macdonald, P. N., Dowd, D. R., Nakajima, S , Galligan, M A , Reeder, M. C., Haussler, C. A., Ozato, K., and Haussler, M. R. Retinoid X receptors stimulate and 9-cis-retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene Mol. Cell. Biol , 13 5907-5917, 1993.
47. 3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis Leukemia (Baltimore). 9: 410-418, 1995
48. 3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature (Lond), 370 382-386 1994.
49. Zhang, X K., Lehmann, J., Hoffmen, B., Dawson, M. I., Cameron, J., Graupner, G., Herman, T , Tran, P., and Pfahl, M. Homodimer formation of retinoid X receptor induced by 9-cis-retinoic acid. Nature (Lond ), 358: 587-591, 1992.
50. 3 results from ligand-induced stabilization. J. Biol Chem., 267; 20082-20086, 1992
51. 3-24-hydroxylase activity in Caco-2 cells An in vitro model of intestinal vitamin D catabolism. Endocrinology. 126: 2868-2875, 1990.
52. Giguere, V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling Endocr Rev., 15: 61-79, 1994
53. Lee, J. W., Ryan, F , Swaffield, J. C., Johnston, S A., and Moore, D. D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature (Lond.) 374 91-94, 1995.
54. Lee, J. W , Choi, H. S., Gyuris, J., Brent, R., and Moore, D. D Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol., 9, 243-254, 1995.
55. Cavailles, V., Dauvois, S., Danielian, P. S., and Parker, M. G. Interaction of proteins with transcriptionally active estrogen receptors Proc. Natl Acad. Sci. USA, 91: 10009-10013, 1994.
56. Chen, J. D., and Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (Lond.), 377: 454-457, 1995.
57. Rosen, E. D , Beninghof, E G., and Koenig, R. J. Dimerization interfaces of thyroid hormone, retinoic acid, vitamin D and retinoid X receptors. J Biol. Chem., 268: 11534-11541, 1993